← Back to search
UNIVERSITY OF MELBOURNE
MELBOURNE, VI, 3010
UnclaimedClaim this profile (free)
Prime contracting experience
2 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | 2019 BAA | — | $573,400 | May 24, 2024 | Jul 2, 2019 – Jul 1, 2021 |
| Prime | Department of Defense Department of the Air Force | ARMY RESEARCH AND DEVELOPMENT - TOWARDS DESIGNING COMPLEX NETWORKS RESILIENT TO STEALTHY ATTACK AND CASCADING FAILURE | — | $384,284 | Apr 21, 2022 | Sep 30, 2018 – Apr 30, 2023 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
13 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | CENTER FOR INFLUENZA DISEASE AND EMERGENCE RESEARCH (CIDER) SUB00002585 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: GA Parent award description: UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE View parent award on USAspending | — | $179,154 | Apr 16, 2026 | — – — |
| Subcontractor | Department of Health and Human Services | CENTER FOR INFLUENZA DISEASE AND EMERGENCE RESEARCH (CIDER) SUB00002585 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: GA Parent award description: UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE View parent award on USAspending | — | $706,514 | May 1, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE SUB00002585 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: GA Parent award description: UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE View parent award on USAspending | — | $610,379 | Jun 13, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | EMORY CEIRR 63039-UM-16F Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: GA Parent award description: AWARD OF THE BASE TO EMORY FOR CEIRR CONTRACT 75N93021C00017 View parent award on USAspending | — | $124,285 | May 9, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | EMORY CEIRR 63039-UM-13E Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: GA Parent award description: AWARD OF THE BASE TO EMORY FOR CEIRR CONTRACT 75N93021C00017 View parent award on USAspending | — | $317,923 | Apr 18, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE SUB00002585 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: GA Parent award description: UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE View parent award on USAspending | — | $375,978 | Jan 11, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | CENTER FOR INFLUENZA VACCINE RESEARCH FOR HIGH RISK POPULATIONS SUB00002219 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: GA Parent award description: COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST AND BROADLY PROTECTIVE IMMU View parent award on USAspending | — | $128,455 | Nov 6, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | THIS PROPOSAL AIMS TO DEVELOP THE APPLICATION OF THE ZINC IONOPHORE PBT2 TO DISRUPT THE ANTIBIOTIC RESISTANCE MECHANISMS OF STREPTOCOCCUS PNEUMONIAE, HAEMOPHILUS INFLUENZAE, AND MORAXELLA CATARRHALIS, THE PRIMARY ETIOLOGICAL AGENTS OF COMMUNITY ACQUIRED BACTERIAL PNEUMONIA (CABP). PBT2 IS A SAFE-FOR-HUMAN-USE HYDROXYQUINOLINE IONOPHORE THAT WAS ORIGINALLY DEVELOPED TO TREAT HUMAN NEURODEGENERATIVE DISEASES AND PROGRESSED TO PHASE II CLINICAL TRIALS. WE HAVE REPURPOSED PBT2 TO FACILITATE THE INTRACELLULAR ACCUMULATION OF ZINC IONS WITHIN BACTERIAL PATHOGENS AND SHOWN THAT THIS DISRUPTS THEIR ABILITY TO RESIST TREATMENT BY BETA-LACTAM AND TETRACYCLINE CLASS ANTIBIOTICS. IN THE CARB-X SUPPORT PROJECT WE WILL DEMONSTRATE THE BREADTH OF ANTIBIOTIC RESISTANCE BREAKAGE BY PBT2 AGAINST A PANEL OF GLOBAL STRAINS, GENERATE FURTHER EFFICACY DATA FOR PBT2+ANTIBIOTIC TREATMENT IN MOUSE MODELS OF LUNG INFECTION, UNDERTAKE A PRELIMINARY PHARMACOKINETIC STUDY, AND PERFORM A GAP ANALYSIS OF THE PRECLINICAL AND CLINICAL DATA FOR PBT2. KC3637 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: MA Parent award description: CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA View parent award on USAspending | — | $143,125 | Sep 8, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE SUB00002585 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: GA Parent award description: UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE View parent award on USAspending | — | $165,233 | Jul 6, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | CENTER FOR INFLUENZA DISEASE AND EMERGENCE RESEARCH SUB00002585 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: GA Parent award description: UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE View parent award on USAspending | — | $160,862 | Jun 30, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | CENTER FOR INFLUENZA DISEASE AND EMERGENCE RESEARCH SUB00002585 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: GA Parent award description: UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE View parent award on USAspending | — | $160,862 | Jun 30, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | DR KATHERINE KEDZIERSKA'S LABORATORY WILL DIRECT EX VIVO DETECTION AND PHENOTYPIC/FUNCTIONAL
ANALYSIS OF INFLUENZA-SPECIFIC CD8+ T CELLS AND CD4+ T CELLS USING PEPTIDE-HLA CLASS I AND CLASS
II TETRAMERS, WHICH WE WILL PROVIDE FOR THE STUDY. WE WILL PROVIDE MONOMERS, TETRAMERSIZE THEM,
OPTIMIZE MULTI-PARAMETER TETRAMER PANELS TOGETHER WITH MULTI-COLOUR FLOW CYTOMETRIC PANELS FOR
PHENOTYPIC AND FUNCTIONAL ANALYSES. SHE WILL WORK CLOSELY WITH DR PAUL THOMAS'S GROUP TO DETECT
DIRECTLY EX VIVO INFLUENZA-SPECIFIC CD8+ AND CD4+ T CELLS BY TETRAMER ENRICHMENT IN HUMAN
SUBJECTS.
THIS WORK WILL BE GIVEN THE HIGHEST PRIORITY. DR KEDZIERSKA'S LABORATORY HAS BEEN RESEARCHING
HUMAN T CELL IMMUNITY TO PANDEMIC, SEASONAL AND NEWLY EMERGED INFLUENZA VIRUSES, ANTI-VIRAL
IMMUNITY IN THE YOUNG, THE ELDERLY, AND INDIGENOUS AUSTRALIANS, AS WELL AS GENERATION OF
IMMUNOLOGICAL MEMORY FOLLOWING INFLUENZA EXPOSURES OVER THE LAST 10 YEARS. THUS, THIS WORK RELATES CLOSELY TO MY RESEARCH INTERESTS SUB000022193A Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: GA Parent award description: COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST AND BROADLY PROTECTIVE IMMU View parent award on USAspending | — | $128,455 | Dec 1, 2021 | — – — |
| Subcontractor | Department of Health and Human Services | TASK/PROJECT SCOPE: THE SCOPE OF THIS TASK IS TO UNDERSTAND MECHANISMS UNDERLYING DISEASE
SEVERITY AND POOR VACCINE EFFICACY IN THE SOUTHERN HEMISPHERE TO INFORM RATIONAL DEVELOPMENT
OF EARLY BIOMARKERS FOR INFLUENZA DISEASE SEVERITY AND IMPROVED THERAPEUTIC INTERVENTION FOR
PATIENTS AT RISK OF DYING. TO ACHIEVE THIS, WE WILL RECRUIT PATIENTS HOSPITALIZED WITH INFLUENZA
DISEASE IN OUR WELL-ESTABLISHED RESPIRATORY DISI COHORT (AIM 1) AND RECRUIT TOP END INDIGENOUS
AUSTRALIANS INTO OUR WELL-ESTABLISHED LIFT/LIFT-V COHORTS AT A ROYAL DARWIN HOSPITAL AND A
REMOTE INDIGENOUS COMMUNITY IN THE NORTHERN TERRITORY (AIM 3). IN OUR DISI COHORT, WE WILL
COLLECT LONGITUDINAL BLOOD SAMPLES AND NASAL SWABS IN PATIENTS WITH SUSPECTED INFLUENZA-LIKE
ILLNESS (ILI). INFLUENZA-POSITIVE PATIENTS ARE PCR-CONFIRMED, WHILE ILI INFLUENZA-NEGATIVE
PATIENTS POSITIVE FOR OTHER RESPIRATORY DISEASES ARE TREATED AS CONTROLS. BLOODS ARE COLLECTED
WITHIN 24-72 HOURS OF HOSPITAL ADMISSION (VISIT 1, V1), EVERY 2-5 DAYS UNTIL DISCHARGE (V2, V3,
V4 ETC.), THEN FOLLOWED UP A30 DAYS LATER. OUR WELL-ESTABLISHED LIFT COHORT REPRESENTS ADULT
INDIGENOUS AUSTRALIANS, EITHER HEALTHY DONORS OR PATIENTS WITH ILIS (LIFT), OR INDIVIDUALS
RECEIVING SEASONAL INFLUENZA VACCINE (LIFT-V). WE HAVE LONGSTANDING RESEARCH RELATIONSHIPS
WITH A REMOTE ABORIGINAL COMMUNITY, WHERE WE HAVE INVESTED IN CAPACITY BUILDING LOCAL
COMMUNITY-BASED ABORIGINAL RESEARCH ASSISTANTS, INCLUDING 4 WHO HAVE COMPLETED A FORMAL
CERTIFICATE 2 IN COMMUNITY-BASED RESEARCH THROUGH CHARLES DARWIN UNIVERSITY. THIS COMMUNITY
WITH A POPULATION OF 2500-3000 IS A TWO-HOUR FLIGHT FROM DARWIN AND HAS A CLINIC, WHICH
PROVIDES PRIMARY HEALTH CARE; UNWELL PATIENTS ARE EVACUATED TO ROYAL DARWIN HOSPITAL (RDH).
WE WILL RECRUIT INTO 2 ARMS (1) HEALTHY INDIGENOUS AUSTRALIANS RECRUITED IN A REMOTE ABORIGINAL
COMMUNITY; (2) HEALTHY INDIGENOUS AUSTRALIANS RECEIVING SEASONAL INFLUENZA VACCINATION
RECRUITED IN A REMOTE ABORIGINAL COMMUNITY, AS ABOVE.. WE WILL HARMONIZE OUR STUDIES WITH
HUMAN COHORT 5 (INDIGENOUS POPULATIONS IN COLUMBIA) SO THE RESULTS CAN BE ANALYZED TOGETHER. SUB00002585 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: GA Parent award description: UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE View parent award on USAspending | — | $158,617 | Oct 11, 2021 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
- Department of DefenseGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.